Cytek Biosciences, Inc. (CTKB) Balance Sheet
As of 2026-06-30 (10-Q), Cytek Biosciences, Inc. (CTKB) reported total assets of $446.9M, total liabilities of $125.0M and shareholders' equity of $322.0M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $73.8M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CTKBCytek Biosciences, Inc.Follow CTKB — free
—
Price chart with a free account
- Market cap
- 726.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 364.6 | 296.6 | 167.3 | 98.7 | 90.9 | 73.8 | |
| Receivables | 29.8 | 48.9 | 55.9 | 60.6 | 62.5 | 49.7 | |
| Inventory | 32.2 | 48.2 | 60.9 | 43.9 | 48.4 | 52.3 | |
| Current assets | 431.7 | 454.0 | 392.1 | 396.4 | 392.0 | 377.9 | |
| Total assets | 463.3 | 519.5 | 494.5 | 499.5 | 461.5 | 446.9 | |
| Current liabilities | 33.2 | 49.0 | 56.2 | 67.7 | 77.8 | 84.3 | |
| Total liabilities | 57.9 | 93.9 | 101.4 | 103.8 | 119.8 | 125.0 | |
| Shareholders' equity | 405.4 | 425.5 | 393.1 | 395.7 | 341.7 | 322.0 |
USD millions · SEC XBRL
Cytek Biosciences, Inc. — questions
- How much cash does Cytek Biosciences, Inc. have?
- $73.8M in cash and cash equivalents as of 2026-06-30.
- What are Cytek Biosciences, Inc.'s total assets?
- $446.9M as of 2026-06-30.
- What is Cytek Biosciences, Inc.'s shareholders' equity?
- $322.0M as of 2026-06-30.
Every figure on this page comes from Cytek Biosciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.